Taiwan Main Orthopaedic Biotechnology have announced that their OOOPDS 3D medical image reconstruction and surgical planning medical software has received TFDA Class-II certification.

OOOPDS is the most comprehensive 3D surgical planning software in Taiwan. It is easy to combine medical-grade 3D printers. The next step is to submit for the USFDA to enter the US and worldwide 3D medical printing markets.

The CEO Wang Min-Liang said Taiwan Main Orthopaedic Biotechnology is well-known innovative medical device company that developed the world's first smart surgical glasses with Augmented Reality technology. "Our smart surgical glasses products obtained the CE mark, and the product has been deployed in the UK, Europe, the Middle East, India, Russia, and other regions. The company is very innovative when it comes to medical software and algorithms", he added.

In recent years, 3D printing technology has gradually matured and has been applied in various related medical fields such as orthopedics, spine, dentistry, etc. However, the certified 3D medical imaging surgical planning is the key point that the printed 3D materials transfer into actual medical products.

OOOPDS is now ready to go into the market with TFDA in Taiwan.